Journal
PLANTA MEDICA
Volume 66, Issue 4, Pages 324-328Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/s-2000-8549
Keywords
iridoids; Scrophularia scorodonia; Scrophulariaceae; anti-inflammatory activity; PGE(2); LTC4; TXB2
Ask authors/readers for more resources
Seven iridoid glycosides isolated from different extracts of Scrophularia scorodonia L., namely bartsioside, aucubin, harpagide, harpagoside, 8-acetylharpagide, scorodioside and scropolioside B, had been evaluated for their in vitro antiinflammatory activity in cellular systems generating COX and LOX metabolites. Structure-activity relationships obtained from in vitro screening results were discussed. Most compounds assayed did not exhibit any significant effect on PGE(2)- and LTC4-release from calcium ionophore-stimulated mouse peritoneal macrophages. In the LTC4-assay, only aucubin showed a significant effect, with an IC50 value of 72 mu M. Harpagoside and harpagide also inhibited release of LTC4, but neither effect reached statistical significance. The release of PGE(2) by mouse peritoneal macrophages stimulated with calcium ionophore was inhibited by harpagoside and 8-acetylharpagide, but this effect is not statistically significant. However, most iridoids assayed showed a significant effect on TXB2-release from calcium ionophore-stimulated human platelets, with inhibition percentages slightly lower than the reference drug ibuprofen. Only harpagide, scorodioside and scropolioside B had no significant effect on TXB2-release. Our results indicate that selective inhibition of the TX-synthase enzyme may be the primary target of action most of these iridoids, and one of the mechanisms through which they exert their anti-inflammatory effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available